A proof-of-concept study of tipifarnib in pancreatic cancer
Latest Information Update: 27 Feb 2020
At a glance
- Drugs Tipifarnib (Primary)
- Indications Pancreatic cancer
- Focus Proof of concept; Therapeutic Use
- Sponsors Kura Oncology
- 25 Feb 2020 According to an Kura Oncology media release, the company expects to initiate this trial in the second half of 2020.
- 11 Nov 2019 New trial record
- 05 Nov 2019 According to an Kura Oncology media release, the initiation of a proof-of-concept study of tipifarnib in pancreatic cancer is expected in 2020.